New hope for tough colorectal cancers? early trial combines three drugs
Disease control
Not yet recruiting
This early-phase trial tests a new drug called nelmastobart, combined with two existing cancer drugs (TAS-102 and bevacizumab), in 45 Chinese patients with advanced colorectal cancer that has not responded to standard treatments. The main goal is to check safety and how the body …
Phase: PHASE1 • Sponsor: STCube, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC